Poolbeg Pharma PLC

DB:7JN Stock Report

Market Cap: €30.2m

Poolbeg Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:7JN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Feb 25Buy€3,802Davy Global Fund Management LimitedCompany61,677€0.062
31 Jan 25Buy€554Davy Global Fund Management LimitedCompany9,162€0.061
30 Jan 25Sell€4,446Davy Global Fund Management LimitedCompany71,501€0.062
29 Jan 25Sell€228Davy Global Fund Management LimitedCompany3,680€0.062
28 Jan 25Sell€10,103Davy Global Fund Management LimitedCompany152,373€0.066
27 Jan 25Buy€15,263Davy Global Fund Management LimitedCompany240,000€0.064
27 Jan 25Sell€0Davy Global Fund Management LimitedCompany136,502€0.066
23 Jan 25Buy€5,358Davy Global Fund Management LimitedCompany93,994€0.057
23 Jan 25Sell€2,759Davy Global Fund Management LimitedCompany48,500€0.057
22 Jan 25Buy€28Davy Global Fund Management LimitedCompany503€0.055
22 Jan 25Sell€14Davy Global Fund Management LimitedCompany250€0.055
21 Jan 25Buy€148Davy Global Fund Management LimitedCompany2,709€0.054
17 Jan 25Buy€532Davy Global Fund Management LimitedCompany9,977€0.053
17 Jan 25Sell€267Davy Global Fund Management LimitedCompany5,000€0.053
16 Jan 25Buy€0Davy Global Fund Management LimitedCompany47,000€0.056
16 Jan 25Sell€2,617Davy Global Fund Management LimitedCompany46,855€0.056
15 Jan 25Buy€0Davy Global Fund Management LimitedCompany217,143€0.06
15 Jan 25Sell€5,709Davy Global Fund Management LimitedCompany100,000€0.057
14 Jan 25Buy€2,206Davy Global Fund Management LimitedCompany37,248€0.059
07 Jan 25Buy€1,549Davy Global Fund Management LimitedCompany28,578€0.054
02 Jan 25Buy€5,318Patrick ReidIndividual95,000€0.056
21 Feb 24Buy€19,513Jeremy SkillingtonIndividual154,764€0.13
19 Feb 24Buy€113,309Cathal FrielIndividual830,000€0.14

Insider Trading Volume

Insider Buying: 7JN insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 7JN?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme379,7080.0759%
Public Companies3,701,7220.74%
Private Companies8,581,3471.72%
Individual Insiders106,174,62321.2%
General Public144,786,04529%
Institutions236,376,55547.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 61.5% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.44%
Cathal Friel
37,219,757€2.3m70.8%no data
6.94%
Michael Kelly
34,714,941€2.1m33.3%no data
6.85%
Platform Capital Holdings Ltd., Asset Management Arm
34,238,041€2.1m-6.9%1.92%
4.01%
HBOS Investment Fund Managers Limited
20,031,827€1.2m-7.07%0.01%
3.96%
Allied Irish Banks Plc., Asset Management Arm
19,800,944€1.2m1.47%0.79%
3.53%
Jarvis Securities plc, Asset Management Arm
17,653,714€1.1m22.2%0.09%
3.24%
Allan Rankin
16,216,038€980.5k0%no data
2.77%
Raglan Road Capital Limited, Asset Management Arm
13,872,633€838.8k0%28.26%
2.49%
Barclays Bank PLC, Wealth and Investment Management Division
12,433,998€751.8k-10.6%0.01%
2.22%
Hedley & Company Stockbrokers Ltd, Asset Management Arm
11,084,260€670.2k0%0.45%
2.2%
Seneca Partners Limited
11,006,157€665.5k49.8%0.07%
1.74%
Dolmen Fund Management
8,692,306€525.6k-2.66%0.21%
1.72%
Dominion Fiduciary Services Limited, Asset Management Arm
8,597,794€519.9k0%99.68%
1.67%
Ian O'Connell
8,326,839€503.5k0%no data
1.37%
UBS Asset Management AG
6,858,590€414.7k-0.11%no data
1.32%
IG Group Holdings Plc, Asset Management Arm
6,594,334€398.7k-52%0.03%
1.24%
Patrick Reid
6,192,077€374.4k0%no data
1.05%
Sterling Investments Management Limited
5,242,590€317.0k0%1.75%
0.96%
DEGIRO B.V., Asset Management Arm
4,781,433€289.1k0%0.1%
0.92%
Bank Julius Bär & Co Ltd., Asset Management Arm
4,623,778€279.6k0%no data
0.88%
Gresham House Asset Management Limited
4,387,436€265.3k0%0.02%
0.8%
Quilter Cheviot Limited
4,006,833€242.3k-1.89%no data
0.8%
HSBC Global Asset Management (UK) Limited
4,004,161€242.1k-34.1%no data
0.74%
Lloyds Banking Group plc
3,701,722€223.8k2.34%no data
0.65%
Charles Stanley & Co. Ltd, Asset Management Arm
3,230,773€195.3k-37.9%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/12 02:30
End of Day Share Price 2025/02/12 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Poolbeg Pharma PLC is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Adam McCarterCavendish
Brian WhiteShore Capital Group Ltd